Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
NYSE:BIO
Price:
286.09 USD
-0.39%
Market Closed
Updated:
May 29, 2024
Bio Rad Laboratories Inc
Additional Paid In Capital
|
Bio Rad Laboratories Inc
Additional Paid In Capital Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bio Rad Laboratories Inc
NYSE:BIO
|
Additional Paid In Capital
$462.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Additional Paid In Capital
$17.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Danaher Corp
NYSE:DHR
|
Additional Paid In Capital
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Additional Paid In Capital
$876.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Additional Paid In Capital
$5.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Additional Paid In Capital
$11B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Bio Rad Laboratories Inc's Additional Paid In Capital?
Additional Paid In Capital
462.6m
USD
462.6m
USD
Based on the financial report for Mar 31, 2024, Bio Rad Laboratories Inc's Additional Paid In Capital amounts to 462.6m USD.
What is Bio Rad Laboratories Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
6%
6%
Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Bio Rad Laboratories Inc have been 1% over the past three years , 3% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
